Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer

NCT02339168 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: Metformin Hydrochloride

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]
[object Object]